Innovative Pathways through the FDA & EMEA Journey
Thursday, July 18, 2019 • Watch for Details
Join your colleagues for a virtual, cross-Atlantic session. We will discuss emerging opportunities as international regulatory bodies listen to researchers. Recent successes and lessons learned will be shared.
You are invited to gather colleagues who already work across the ocean, or those who would like to spark fresh collaborations.
In this Launch session, presenters will share cases where innovative approaches for trial design, ways to receive expert guidance, and lessons learned you can leverage as you take your therapy through the regulatory process.
About Westchester Biotech Project Europe:
Direct and agile collaboration without borders has become crucial to speeding up innovation and market access. The digital revolution has enabled landmark scientific and medical research progress unpredictable even a few years back. At the same time, expanding capital for early stage start-ups is enabling the future success of these innovations.
To stimulate and strengthen connections across the Atlantic, we have recently signed a Memorandum of Understanding for Westchester Biotech Project Europe • Read Press Release
This collaboration further engages the US-European scientific community, strengthening our connections with the international innovation scene.
Mutual exchange programs are in the works, honoring the pivotal relationship between scientific disciplines and international regions. Westchester Biotech Project Europe aims to facilitate and accelerate the match between innovation and capital, speeding access to market.
Westchester Biotech Project Europe works closely with public and private partners such as Foundation Sophia and Communauté d'agglomération de Sophia Antipolis, the organization representing the cities/towns engaged in the development of Sophia Antipolis. Other private and public partners will be joining soon. Engaging and involving organizations from across Europe will result in collaborative resources to the benefit of all parties involved.
Sophia Antipolis is a 6,000-acre technology campus located southwest of Nice. Known as the “French Palo Alto,” Sophia Antipolis is regarded as an R&D and technology start-up hub, with as many as 2,500 companies, 4,500 researchers and 5,500 students from more than 64 countries located there. Sophia Antipolis specializes in computing, electronics, pharmacology, and biotechnology.
Philippe Salphati, PharmD, Managing Director, France-Switzerland & Partner, Tefen Management Consulting
Formerly VP, Global Marketing, Sanofi Pasteur
Dr. Salphati has over 25 years of global leadership experience in major life science companies, including Sanofi, which brought him to Rye for several years. He holds a Doctor of Pharmacy degree from the School of Pharmacy, Paris XI, and an MBA from the International University of America in San Francisco.
Westchester Biotech Project Europe is a French-based NGO working to develop strong relationships throughout the continent, UK, and Israel. These connections will lead to fresh collaborations with US-based researchers and innovation centers.
To get involved, send a note
and we'll connect you! firstname.lastname@example.org
Westchester Biotech Project
The Westchester Biotech Project brings together researchers, engineers, and data scientists from across therapeutics, diagnostics, and devices. Based in Westchester County, NY, this is a borderless initiative with opportunities for local, national, and international collaboration.
Westchester County, NY is a beautiful environment a stone’s throw from New York and right on the path between Boston and Washington. As we work together to strengthen research and business relationships, opportunities will grow for all of us!
With recent lease signing for the North 60 project, Westchester County is positioned to grow as a magnet for the international biotech community. This is a perfect moment to strengthen international ties, and leverage lessons learned from emerging discovery-to-commercialization models. By building partnerships that endure, we can realize profound biomedical progress, and even cures.